Evidence map›Paper›PMID 34422940›Full record

ArticleFrontiers in veterinary science2021

Post-vaccination Monitoring to Assess Foot-and-Mouth Disease Immunity at Population Level in Korea.

Mi-Young Park, You Jin Han, Eun-Jin Choi, HeeYeon Kim, Rokeya Pervin, Wonseok Shin, Doheon Kwon, Jae Myoung Kim, Hyun Mi Pyo

Open access · goldAbstract read
In one paragraph

Article in Frontiers in veterinary science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Multiple incursions of foot-and-mouth disease virus serotype O into the Republic of Korea between 2010 and 2019.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Mi-Young ParkFoot and Mouth Disease Diagnostic Division, Animal and Plant Quarantine Agency, Gimcheon-si, South Korea.
You Jin HanFoot and Mouth Disease Diagnostic Division, Animal and Plant Quarantine Agency, Gimcheon-si, South Korea.
Eun-Jin ChoiFoot and Mouth Disease Diagnostic Division, Animal and Plant Quarantine Agency, Gimcheon-si, South Korea.
HeeYeon KimFoot and Mouth Disease Diagnostic Division, Animal and Plant Quarantine Agency, Gimcheon-si, South Korea.
Rokeya PervinFoot and Mouth Disease Diagnostic Division, Animal and Plant Quarantine Agency, Gimcheon-si, South Korea.
Wonseok ShinFoot and Mouth Disease Diagnostic Division, Animal and Plant Quarantine Agency, Gimcheon-si, South Korea.
Doheon KwonFoot and Mouth Disease Diagnostic Division, Animal and Plant Quarantine Agency, Gimcheon-si, South Korea.
Jae Myoung KimFoot and Mouth Disease Diagnostic Division, Animal and Plant Quarantine Agency, Gimcheon-si, South Korea.
Hyun Mi PyoFoot and Mouth Disease Diagnostic Division, Animal and Plant Quarantine Agency, Gimcheon-si, South Korea.
Animal and Plant Quarantine Agency · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In South Korea, domestic cattle, pigs, and goats were subjected to mandatory foot-and-mouth disease (FMD) vaccination and year-round serosurveillance since 2011. In 2020, approximately USD 95 million was spent solely for FMD vaccine purchase for 59 million livestock, and 1.25 million samples were tested to estimate the population immunity and demonstrate the absence of virus circulation. As the FMD vaccination program was revised in 2018, the post-vaccination monitoring (PVM) was designed to evaluate the effectiveness of the vaccine program of three vaccines approved for routine use. To this end, monitoring post-vaccination immunity has been conducted by collecting 35,626 serum samples at 28 days post-vaccination following regular national vaccinations, which were carried out in April and in October in 2020. The design of the serological test for PVM was specially targeted at particular livestock groups, including dairy cattle, goats, and beef cattle aged 6-12 months, which were generally estimated to have a low expected seroprevalence. The risk factors had also been identified, considering the increased likelihood of infection in a particular location, herd size, and husbandry system applied in a targeted sample collection. Serum sample collection and SP-O and NSP antibody tests were performed by local veterinary laboratories using commercially available ELISAs. The current FMD vaccination program, which was performed twice a year following the regimen of primary vaccination and boost, resulted in over 80% population immunity. The seroprevalence monitored after the vaccination in fall was higher than the one studied in spring except in pigs. It was demonstrated that the seroprevalence of risk-based targeted samples ranged from 93.8 to 100% in cattle, 63.2 to 100% in pigs, and 20.0 to 100% in goats. Of note is the area near the North Korean borders which showed a relatively low seroprevalence among the targeted regions, and no NSP sero-positive reactor was detected in this region. When subpopulation immunity at the individual level was assessed, the seroprevalence in young cattle stock was slightly lower (95.8%) than that of adults (98.4%). In conclusion, the FMD vaccination campaign has been successfully implemented in Korea, and the PVM can be a supplementary program for massive routine surveillance in terms of providing timely information needed both to estimate population immunity and to properly target "risk-based surveillance."

Indexed as

foot-and-mouth disease virusmass vaccinationpopulation immunitypost-vaccination monitoringvaccination campaign

Identifiers

PMID34422940
PMCPMC8371437
OpenAlexW3187482484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.